» Articles » PMID: 17396268

[Teratoma of the Ovary. Clinical and Pathological Differences Between Mature and Immature Teratomas]

Overview
Journal Pathologe
Specialty Pathology
Date 2007 Mar 31
PMID 17396268
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Teratomas are the most frequent germ cell tumors of the ovary. Two main groups can be distinguished: mature and immature teratomas. Mature teratomas are benign tumors, which are most often composed of derivatives of two or three germ cell layers. Only in rare cases is the transition into a malignant tumor observed (most often squamous cell carcinoma). In contrast, immature teratomas are malignant ovarian tumors. They contain immature tissue elements in addition to the mature components, most often consisting of immature neural tissue. Histologically, this tumor component can be identified as neurotubules or rosettes. The proportion of immature tissue elements defines the grade of immaturity. Four grades have been defined in to the WHO classification. Grade 0 represents a mature teratoma. With the exception of childhood cases, grade 2 and 3 immature teratomas are treated with chemotherapy. In childhood cases, foci of yolk sac tumor (YST) must be looked for, since this determines the prognosis. If a focus of YST is present, the patient is treated with chemotherapy. Both in cases of mature and immature teratoma, peritoneal implants can be found (gliomatosis peritonei), which are also graded. In cases of immature peritoneal implants, patients are also treated with chemotherapy. Gliomatosis peritonei is most likely derived from metaplasia of subperitoneal stem cells; it does not represent a metastatic disease of the ovarian teratoma.

Citing Articles

Treatment of Immature Teratoma Associated with Ovarian Endometrioma: A Case Report.

Moghaddam S, Sarchami N, Rahbari A J Reprod Infertil. 2023; 24(3):212-215.

PMID: 37663426 PMC: 10471947. DOI: 10.18502/jri.v24i3.13278.


Primary adrenal mature teratoma: A rare case report and review of literature.

Assarrar I, Harhar M, Zerrouki D, Draoui N, Miry A, Bennani A Ann Med Surg (Lond). 2022; 75:103422.

PMID: 35386796 PMC: 8977937. DOI: 10.1016/j.amsu.2022.103422.


Giant High-Grade Immature Teratoma of the Central Nervous System (CNS) in an Infant: A Case Report.

Riazi A, Larry M, Mokhtari A, Abdali H, Asfia M, Bagherieh S Am J Case Rep. 2021; 22:e932752.

PMID: 34949754 PMC: 8713080. DOI: 10.12659/AJCR.932752.


Primary adrenal teratoma: Clinical characteristics and retroperitoneal laparoscopic resection in five adults.

Li S, Li H, Ji Z, Yan W, Zhang Y Oncol Lett. 2016; 10(5):2865-2870.

PMID: 26722254 PMC: 4665718. DOI: 10.3892/ol.2015.3701.


Immature ovarian teratoma with unusual gliomatosis.

Gheorghisan-Galateanu A, Terzea D, Carsote M, Poiana C J Ovarian Res. 2013; 6(1):28.

PMID: 23590935 PMC: 3637604. DOI: 10.1186/1757-2215-6-28.

References
1.
GONZALEZ-CRUSSI F, Winkler R, Mirkin D . Sacrococcygeal teratomas in infants and children: relationship of histology and prognosis in 40 cases. Arch Pathol Lab Med. 1978; 102(8):420-5. View

2.
Harms D, Janig U, Gobel U . Gliomatosis peritonei in childhood and adolescence. Clinicopathological study of 13 cases including immunohistochemical findings. Pathol Res Pract. 1989; 184(4):422-30. DOI: 10.1016/S0344-0338(89)80038-X. View

3.
Linder D, McCaw B, Hecht F . Parthenogenic origin of benign ovarian teratomas. N Engl J Med. 1975; 292(2):63-6. DOI: 10.1056/NEJM197501092920202. View

4.
Kwan M, Kalle W, Lau G, Chan J . Is gliomatosis peritonei derived from the associated ovarian teratoma?. Hum Pathol. 2004; 35(6):685-8. DOI: 10.1016/j.humpath.2004.01.025. View

5.
Poulos C, Cheng L, Zhang S, Gersell D, Ulbright T . Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol. 2006; 19(6):766-71. DOI: 10.1038/modpathol.3800596. View